Skip to content

Board of Directors

  • Daniel Amburn, UCB, Board Chairman
  • Tom Adams, Pairwise
  • Andrew Barnhill, IQVIA
  • Sinu Bhandaru, Precision BioSciences
  • Matt Boyer, Pappas Capital
  • Christopher Capel, Smith Anderson
  • Matthew Cooke, Davis Moore
  • Lisa Davidson, Syneos Health
  • Neal Fowler, Pathalys Pharma
  • Kent Geer, MED1 Ventures
  • Rachel Hardin, SAS
  • Deepak Jain, ProKidney
  • Patrick Jordan, Mycovia
  • Lauren Joyce, Hughes Pittman & Gupton
  • Toni Lockett, PricewaterhouseCoopers
  • Michelle Logan, Thermo Fisher Scientific/Patheon
  • Bennett Love, BioKier
  • Mike McBrierty, Biogen
  • Julie Broadus Meigs, Womble Bond Dickinson
  • Sheila Mikhail, AskBio
  • John Mikszta, BD
  • Heather O'Keefe, Novozymes
  • Buck Phillips, Ribometrix
  • Russ Read, National Center for the Biotechnology Workforce
  • Joe Ruiz, Enzerna Biosciences
  • Marlene Sanders, Merck & Co.
  • Scott Sewell, Cook Medical
  • Kseniya Simpson, Hatteras Venture Partners
  • Leonardo Costa Siqueira, Novo Nordisk
  • Blake Stevens, Alexandria Real Estate Equities
  • Susan Thomason, IQVIA
  • Jon Tucker, Pfizer
  • Christine Vannais, Fujifilm Diosynth
  • Daniel VonDielingen, Lilly RTP
  • Peter Wirth, RTI International